119 related articles for article (PubMed ID: 3008680)
1. HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, Spain.
Tor J; Muga R; Argelagues E; Rey-Joly C; Foz M; Ribas-Mundó M
Arch Intern Med; 1986 Apr; 146(4):805. PubMed ID: 3008680
[No Abstract] [Full Text] [Related]
2. A stage model of HTLV-III LAV infection in intravenous drug users.
Des Jarlais DC; Friedman SR; Spira TJ; Zolla-Pazner S; Marmor M; Holzman R; Mildvan D; Yancovitz S; Mathur-Wagh U; Garber J
NIDA Res Monogr; 1986; 67():328-34. PubMed ID: 3018574
[No Abstract] [Full Text] [Related]
3. [Prevalence of antibodies against human T-lymphotropic virus type III (HTLV-III) in parenteral drug addicts in the Barcelona area].
Muga R; Tor J; Argelagués E; Rey-Joly C; Foz M; Ribas-Mundó M
Med Clin (Barc); 1986 Jan; 86(3):97-9. PubMed ID: 3457230
[No Abstract] [Full Text] [Related]
4. [Chronic generalized lymphadenopathy with splenomegaly associated with HTLV-III virus antibodies].
Mijović A; Stevanović G; Brkić S; Dimitrijević M; Rolović Z; Ruvidić R
Srp Arh Celok Lek; 1986 Jan; 114(1):109-20. PubMed ID: 3014667
[No Abstract] [Full Text] [Related]
5. [HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria].
Pont J; Neuwald C; Kunz C; Werdenich W
Wien Klin Wochenschr; 1986 Jul; 98(14):454-7. PubMed ID: 3019019
[TBL] [Abstract][Full Text] [Related]
6. [Human T-lymphotropic virus (HTLV-III) antibodies in intravenous drug addicts from the Valencia community].
Rodrigo JM; Serra MA; Aguilar E; Ample I; Gimeno V; del Olmo JA; Escudero A; Aparisi L; Wassel A; Sanmartín B
Med Clin (Barc); 1986 Jan; 86(3):89-92. PubMed ID: 3007886
[No Abstract] [Full Text] [Related]
7. [Seropositivity against antigens of the HTLV-III lymphotropic virus in different communities from the Barcelona area].
Barrera Sala JM; Ercilla MG; Gelabert A; Castillo R
Med Clin (Barc); 1986 Jan; 86(3):129-30. PubMed ID: 3007882
[No Abstract] [Full Text] [Related]
8. Immunological abnormalities in intravenous drug abusers and relationship to the prolonged generalized lymphadenopathy syndrome in Italy.
De Paoli P; Reitano M; Battistin S; Martelli P; Villalata D; Bergamo F; Tirelli U; Carbone A; Diodato S; Bosio R
Clin Exp Immunol; 1986 Jun; 64(3):451-6. PubMed ID: 3024880
[TBL] [Abstract][Full Text] [Related]
9. [Anti-HTLV-III in hemophilic patients in Barcelona].
Hernández Sánchez JM; Piqueras J; Vila M; Tusell J; Triginer J
Sangre (Barc); 1985; 30(5):857-63. PubMed ID: 3003939
[No Abstract] [Full Text] [Related]
10. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
[No Abstract] [Full Text] [Related]
11. [Prevalence of anti-LAV/HTLV-III in prostitutes in Seville].
Pineda JA; Leal M; García de Pesquera F; Sánchez-Quijano A; Rivera F; Lissen E
Med Clin (Barc); 1986 Mar; 86(12):498-500. PubMed ID: 3012223
[No Abstract] [Full Text] [Related]
12. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
Soranzo ML; Salassa B; Daziano E; Paggi GC
Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
[TBL] [Abstract][Full Text] [Related]
13. HTLV-III seropositivity in 1971-1972 parenteral drug abusers--a case of false positives or evidence of viral exposure?
Moore JD; Cone EJ; Alexander SS
N Engl J Med; 1986 May; 314(21):1387-8. PubMed ID: 3010112
[No Abstract] [Full Text] [Related]
14. [Usefulness of the determination of anti-HTLV-III antibodies in parenteral drug addicts].
Forteza-Rei J; Altés J; Villalonga C; Riera M
Med Clin (Barc); 1986 Apr; 86(14):610. PubMed ID: 3014238
[No Abstract] [Full Text] [Related]
15. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region.
Robert-Guroff M; Weiss SH; Giron JA; Jennings AM; Ginzburg HM; Margolis IB; Blattner WA; Gallo RC
JAMA; 1986 Jun; 255(22):3133-7. PubMed ID: 3009910
[TBL] [Abstract][Full Text] [Related]
16. HTLV-III antibody in East Africa.
N Engl J Med; 1986 Jul; 315(4):259-60. PubMed ID: 3014335
[No Abstract] [Full Text] [Related]
17. HTLV-III antibody in Swiss and English intravenous drug abusers.
Mortimer PP; Vandervelde EM; Jesson WJ; Pereira MS; Burkhardt F
Lancet; 1985 Aug; 2(8452):449-50. PubMed ID: 2863476
[No Abstract] [Full Text] [Related]
18. Antibodies to AIDS-associated retrovirus (HTLV-III/LAV) in drug addicts from Vizcaya, northern Spain.
Merino F; Esparza B; Aizpiri J; Fernandez J; de Masdelval L; Arrieta A; Velazquez M; Volsky DJ; San Cristobal E; de Izaguirre A
AIDS Res; 1986; 2(2):133-40. PubMed ID: 3013221
[TBL] [Abstract][Full Text] [Related]
19. HTLV-III antibodies in drug addicts in Spain.
Rodrigo JM; Serra MA; Aguilar E; del Olmo JA; Gimeno V; Aparisi L
Lancet; 1985 Jul; 2(8447):156-7. PubMed ID: 2862347
[No Abstract] [Full Text] [Related]
20. Increasing prevalence of HTLV-III infection in intravenous drug users in Liguria, Italy.
Cuneo Crovari P; Terragna A; Robert L; Orlando G; Rizzo F; Piuma-Fusco M; Icardi GC; Papa D; Di Ponzio A; Auteri G
Boll Ist Sieroter Milan; 1985; 64(4):339-42. PubMed ID: 3000406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
